Abstract: Oligonucleotides are provided herein that inhibit MARC1 expression. Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders and/or conditions associated with MARC1 expression.
| # | Name | Date |
|---|---|---|
| 1 | 202347086505-STATEMENT OF UNDERTAKING (FORM 3) [18-12-2023(online)].pdf | 2023-12-18 |
| 2 | 202347086505-Sequence Listing in txt [18-12-2023(online)].txt | 2023-12-18 |
| 3 | 202347086505-Sequence Listing in PDF [18-12-2023(online)].pdf | 2023-12-18 |
| 4 | 202347086505-PRIORITY DOCUMENTS [18-12-2023(online)].pdf | 2023-12-18 |
| 5 | 202347086505-POWER OF AUTHORITY [18-12-2023(online)].pdf | 2023-12-18 |
| 6 | 202347086505-FORM 1 [18-12-2023(online)].pdf | 2023-12-18 |
| 7 | 202347086505-DRAWINGS [18-12-2023(online)].pdf | 2023-12-18 |
| 8 | 202347086505-DECLARATION OF INVENTORSHIP (FORM 5) [18-12-2023(online)].pdf | 2023-12-18 |
| 9 | 202347086505-COMPLETE SPECIFICATION [18-12-2023(online)].pdf | 2023-12-18 |
| 10 | 202347086505-FORM 18 [21-12-2023(online)].pdf | 2023-12-21 |
| 11 | 202347086505-Proof of Right [04-06-2024(online)].pdf | 2024-06-04 |